Amgen Aktie
ISIN: ARDEUT110665
18.10.2024 13:32:00
|
Is Amgen Stock a Buy?
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months. Despite a string of solid earnings reports from the biotechnology giant and Dow Jones Industrial Average component, pending clinical-trial data from its drug pipeline has added a layer of uncertainty.On the other hand, the company continues to deliver strong growth with overall positive fundamentals. So is now a good time to pick up some Amgen shares? Here's what you need to know.Amgen is recognized as a biotech pioneer with a long history of groundbreaking discoveries. From developing Epogen in the 1980s as one of the first recombinant DNA technology-based treatments for anemia to launching the first-of-its-kind monoclonal-antibody therapy against cancer with Neulasta in 2003, that tradition of innovation has continued.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Analysen zu Amgen Inc Cert.Deposito Arg.Repr. 0.2 Shsmehr Analysen
Aktien in diesem Artikel
Amgen Inc Cert.Deposito Arg.Repr. 0.2 Shs | 13 700,00 | -8,18% |
|
Amgen Inc. | 242,10 | 0,21% |
|